Ghent University Academic Bibliography

Show Sort by

Your filters: cql: parent exact "ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY"

Add to list
- Conference Paper
- C3
Dupilumab improves CRSWNP/asthma outcomes in patients with CRSWNP and comorbid asthma irrespective of asthma characteristics

W Busse, I Pavord, S Siddiqui, Asif H. Khan (UGent) , A Praestgaard, S Nash, J Jacob-Nara, P Rowe and Y Deniz

(2021) ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY. In Annals of Allergy Asthma & Immunology 127(5). p.S52-S53
Add to list
- Conference Paper
- C3
Impact of dupilumab on sleep/function scores in patients with chronic rhinosinusitis with nasal polyps

W Busse, A Wellman, Claus Bachert (UGent) , S Siddiqui, H Zhang, Asif H. Khan (UGent) , J Jacob-Nara, P Rowe and Y Deniz

(2021) ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY. In Annals of Allergy Asthma & Immunology 127(5). p.S53-S53
Add to list
- Conference Paper
- C3
Dupilumab leads to clinical asthma remission indicative of comprehensive improvement in patients with asthma

I Pavord, W Busse, E Israel, S Szefler, Z Chen, Asif H. Khan (UGent) , D Lederer and Y Zhang

(2021) ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY. In Annals of Allergy Asthma & Immunology 127(5). p.S33-S33
Add to list
- Journal Article
- A1
- open access
Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma

Tanya M. Laidlaw, Claus Bachert (UGent) , Nikhil Amin, Martin Desrosiers, Peter Hellings (UGent) , Joaquim Mullol, Jorge F. Maspero, Philippe Gevaert (UGent) , Mei Zhang, Xuezhou Mao, et al.

(2021) ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY. 126(5). p.584-592.e1
Add to list
Anti-Bet v_1 MABs reduced basophil responsiveness to birch pollen stimulation ex-vivo in birch allergic patients

Jarno De Craemer (UGent) , Philippe Gevaert (UGent) , Natalie De Ruyck (UGent) , O. Herrera, M. Deveaux, D. Ramesh, L. Perlee, M. O'Brien and C. Wang

(2020) ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY. In Annals of Allergy Asthma & Immunology 125(5). p.S19-S19
Add to list
Anti-Bet v_1 MAB cocktail reduced birch allergic symptoms within one week, sustained over two months

Philippe Gevaert (UGent) , J. DeCraemer, S. Rottey, J. DeHoon, P. Hellings, B. Volckaert, C. Wang, M. Deveaux, D. Ramesh, L. Perlee, et al.

(2020) ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY. In Annals of Allergy Asthma & Immunology 125(5). p.S19-S19
Add to list
Continued safety / efficacy of omalizumab in chronic rhinosinusitis with nasal polyps : an open-label extension study

Philippe Gevaert (UGent) , R. Saenz, J. Corren, J. Han, J. Mullol, S. Lee, R. Zhao, M. Howard, K. Wong, L. Islam, et al.

(2020) ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY. In Annals of Allergy Asthma & Immunology 125(5). p.S15-S15
Add to list
- Conference Paper
- C3
Indirect treatment comparison of biologics used for the treatment of chronic rhinosinusitis with nasal polyps

A. Peters, J. Han, P. Hellings, E. Heffler, Philippe Gevaert (UGent) , Claus Bachert (UGent) , Y. Xu, C. Chuang, L. Mannent, P. Guyot, et al.

(2020) ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY. In Annals of Allergy Asthma & Immunology 125(5). p.S48-S49
Add to list
- Journal Article
- A1
- open access
Efficacy of dupilumab on clinical outcomes in patients with asthma and perennial allergic rhinitis

William W Busse, Jorge F Maspero, Yufang Lu, Jonathan Corren, Nicola A Hanania, Bradley E Chipps, Constance H Katelaris, J Mark FitzGerald, Santiago Quirce, Linda B Ford, et al.

(2020) ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY. 125(5). p.565-576
Add to list
- Conference Paper
- C3
Omalizumab efficacy and safety in nasal polyposis : results from two parallel, double-blind, placebo-controlled trials

Philippe Gevaert (UGent) , Claus Bachert (UGent) , J. Corren, J. Mullol, J. Han, R. Ow, L. Islam, M. Howard, R. Owen, K. Wong, et al.

(2019) ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY. In Annals of Allergy Asthma & Immunology 123(5). p.S17-S17

Academic Bibliography

Dupilumab improves CRSWNP/asthma outcomes in patients with CRSWNP and comorbid asthma irrespective of asthma characteristics

Impact of dupilumab on sleep/function scores in patients with chronic rhinosinusitis with nasal polyps

Dupilumab leads to clinical asthma remission indicative of comprehensive improvement in patients with asthma

Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma

Anti-Bet v_1 MABs reduced basophil responsiveness to birch pollen stimulation ex-vivo in birch allergic patients

Anti-Bet v_1 MAB cocktail reduced birch allergic symptoms within one week, sustained over two months

Continued safety / efficacy of omalizumab in chronic rhinosinusitis with nasal polyps : an open-label extension study

Indirect treatment comparison of biologics used for the treatment of chronic rhinosinusitis with nasal polyps

Efficacy of dupilumab on clinical outcomes in patients with asthma and perennial allergic rhinitis

Omalizumab efficacy and safety in nasal polyposis : results from two parallel, double-blind, placebo-controlled trials

Contents

Support

Contact